Market Capitalization (Millions $) |
55 |
Shares
Outstanding (Millions) |
14 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-31 |
Cash Flow (TTM) (Millions $) |
-32 |
Capital Exp. (TTM) (Millions $) |
1 |
Tempest Therapeutics Inc
Tempest Therapeutics Inc is a biotechnology company that specializes in the discovery and development of novel small molecule therapeutics. The company focuses on targeting the immune system to address various forms of cancer. Tempest Therapeutics aims to develop innovative treatments that can modify the tumor microenvironment and enhance immune responses against cancer cells. Their research is centered around understanding the intricate interplay between the immune system and cancer to develop effective therapies that can improve patient outcomes.
Company Address: 2000 Sierra Point Parkway Brisbane 94005 CA
Company Phone Number: 798-8589 Stock Exchange / Ticker: NASDAQ TPST
TPST is expected to report next financial results on March 21, 2024. |
|
|